Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$61.6M
47M shares
52-week range
$0.99 – $2.99
21% from low
Exchange
NASDAQ
CS
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
www.mindwalkai.comNo one on the platform currently holds HYFT.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 232,480 | $262.7K |
No one on the platform has traded HYFT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$HYFT we will get an announcement soon that someone has taken a stake in the company. Will see
View on StockTwits ↗$HYFT tomorrow would be the perfect day to drop some big news
View on StockTwits ↗$HYFT The pieces are starting to come together. For years we heard about HYFT and the science behind it. Now we're finally seeing what MindWalk intends to build around that technology. HYFT — 660M biological patterns and 25 BILLION relationships built from roughly two decades of biological curation. ReefIQ — turns that biological intelligence into a context layer that AI can actually reason over. LensAI — applies the reasoning. B Cell Llama — brings it into actual antibody discovery and the wet lab. And now the pipeline. Dengue. Universal influenza. GLP-1/longevity. ALK-1. The influenza work may be one of the best demonstrations yet of why HYFT could be different. MindWalk says it identified a functional biological signature that remains conserved even as the virus mutates and its genetic sequence changes. Then add AMD showcasing ReefIQ on Instinct, recurring LensAI customer arrangements, and a structure designed to potentially finance internally discovered assets without forcing the parent company to fund every program itself. This isn't starting to look like another AI drug-discovery company. It's starting to look like an entire Bio-Native discovery ecosystem—from biological intelligence, to context, to AI reasoning, to wet-lab discovery, to proprietary therapeutic assets. At a ~$60M valuation, Come on! The technology is there. The platform is there. The pipeline is forming. Now let's get a management team in there that can close major industry deals, monetize what MindWalk has built, and finally deliver the shareholder value this technology deserves
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $20M | +27.4% | $-0.31 | $-0.33–$-0.30 | — | 2 |
| 2028 | $25M | +23.0% | $-0.24 | $-0.25–$-0.23 | — | 1 |
| 2029 | $31M | +25.0% | $-0.14 | $-0.17–$-0.12 | — | 2 |
| 2030 | $38M | +21.9% | $-0.04 | $-0.04–$-0.04 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-22 | $-0.05 | $-0.06 | -12.8% |
| 2026-03-12 | $-0.04 | $-0.06 | -50.0% |
| 2025-12-15 | $-0.01 | $-0.05 | -400.0% |
| 2025-09-15 | $-0.04 | $-0.07 | -75.0% |
| 2025-07-29 | $-0.02 | $-0.04 | -100.0% |
| 2025-03-28 | $-0.06 | $-0.06 | +0.0% |
| 2024-12-10 | $-0.09 | $-0.09 | +0.0% |
| 2024-09-16 | $-0.09 |
| $-0.11 |
| -22.2% |
| $116M |
| — |
| CLNNClene Inc. | $4.14 | -1.19% | $53M | — |
| FBIOFortress Biotech, Inc. | $2.93 | -1.68% | $97M | — |
Source: Financial Modeling Prep · peers by sector/industry